Kourtney Kardashian showcased her new signature product, which she describes as a "breakthrough innovation" in weight loss pills. Will you be tempted? Each of the entrepreneurial Kardashian-Jenner sisters not only represents a brand but also owns their own businesses.

Amycretin, an oral weight loss pill developed by the makers of Wegovy, led to a 13.1% weight loss over three months in early trial results.

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers report.

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with diet and exercise.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As Business Insider and other outlets report, Kardashian Barker's brand Lemme has launched a new line of oral supplements marketed as an alternative to actual glucagon-like peptide-1 drugs like Ozempic and Wegovy.